In the studies of other gynecologic tumors, such as cervical carcinoma and ovarian cancer, overexpressed fibulin-4 was also found in cancer tissues and strongly invasive cells, and high expression of fibulin-4 was associated with tumor progression and poor prognosis [9, 15]. This evidence concerns the gene EFEMP2 and ovarian carcinoma.